España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Longboard Pharmaceuticals
LBPH
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$35.95
0
0.00%
Pre-Market: Jul 19, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Longboard Pharmaceuticals (LBPH) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Longboard Pharmaceuticals (NASDAQ:LBPH) Stock
Longboard Pharmaceuticals Stock (NASDAQ: LBPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Baird Maintains Outperform on Longboard Pharm...
Benzinga Newsdesk
Wednesday, July 03, 2024
Top 3 Health Care Stocks That May Crash This Quarter
Avi Kapoor
Tuesday, July 02, 2024
Citigroup Maintains Buy on Longboard Pharmace...
Benzinga Newsdesk
Evercore ISI Group Maintains Outperform on Lo...
Benzinga Newsdesk
Monday, July 01, 2024
Longboard Pharmaceuticals Announces FDA Grant...
Benzinga Newsdesk
Thursday, June 20, 2024
Evercore ISI Group Maintains Outperform on Lo...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Lo...
Benzinga Newsdesk
Tuesday, June 11, 2024
B. Riley Securities Maintains Buy on Longboar...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Longboa...
Benzinga Newsdesk
Monday, June 10, 2024
Longboard Pharmaceuticals Announces Interim R...
Benzinga Newsdesk
Tuesday, May 07, 2024
HC Wainwright & Co. Reiterates Buy on Longboa...
Benzinga Newsdesk
Friday, May 03, 2024
Cantor Fitzgerald Reiterates Overweight on Lo...
Benzinga Newsdesk
Wedbush Maintains Outperform on Longboard Pha...
Benzinga Newsdesk
Thursday, May 02, 2024
Longboard Pharmaceuticals Q1 EPS $(0.42) Beat...
Benzinga Newsdesk
Wednesday, May 01, 2024
Baird Initiates Coverage On Longboard Pharmac...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Longboa...
Benzinga Newsdesk
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Lo...
Benzinga Newsdesk
Wednesday, April 03, 2024
Longboard Pharmaceuticals To Present Data Fro...
Benzinga Newsdesk
Friday, March 15, 2024
HC Wainwright & Co. Maintains Buy on Longboar...
Benzinga Newsdesk
Wednesday, March 13, 2024
Cantor Fitzgerald Reiterates Overweight on Lo...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Longboard Ph...
Benzinga Newsdesk
Tuesday, March 12, 2024
Recap: Longboard Pharmaceuticals Q4 Earnings
Benzinga Insights
Longboard Pharmaceuticals Reports FY23 EPS $(...
Benzinga Newsdesk
Friday, February 16, 2024
Citigroup Initiates Coverage On Longboard Pha...
Benzinga Newsdesk
Monday, January 29, 2024
Pfizer Dissolves Stake In Longboard Pharmaceu...
Benzinga Newsdesk
Friday, January 26, 2024
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Friday, January 19, 2024
Looking Into Longboard Pharmaceuticals's Recent Short Interest
Benzinga Insights
Tuesday, January 16, 2024
Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on Lon...
Benzinga Newsdesk
Monday, January 08, 2024
HC Wainwright & Co. Maintains Buy on Longboar...
Benzinga Newsdesk
Thursday, January 04, 2024
Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay
Avi Kapoor
Longboard Pharmaceuticals Prices Upsized $210...
Benzinga Newsdesk
Wednesday, January 03, 2024
Why Longboard Pharmaceuticals Stock Is Falling
Henry Khederian
Longboard Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
Tuesday, January 02, 2024
Longboard Pharmaceuticals Commenced A $150M U...
Benzinga Newsdesk
Crude Oil Down 2%; Tesla Deliveries Top Estimates
Avi Kapoor
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
Vandana Singh
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dow Turns Higher; Anavex Life Sciences Shares Plunge
Avi Kapoor
Guggenheim Maintains Buy on Longboard Pharmac...
Benzinga Newsdesk
Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why
Vandana Singh
Cantor Fitzgerald Maintains Overweight on Lon...
Benzinga Newsdesk
Dow Down 100 Points; US Manufacturing PMI Falls In December
Avi Kapoor
Stat News Reporter Adam Feuerstein Posts On X...
Benzinga Newsdesk
Longboard Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Market-Moving News for January 2nd
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Longboard Pharmaceuticals Announces Topline D...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch